Skip to main content
Simcere Pharmaceutical Group Limited logo

Simcere Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · S2P ISIN · HK0000658531 HKEX Manufacturing
Open in API
Filings indexed 577 across all filing types
Latest filing 2022-06-01 Notice of Dividend Amou…
Country CN China
Listing HKEX S2P

About Simcere Pharmaceutical Group Limited

https://www.simcere.com/en/

Simcere Pharmaceutical Group Limited is an R&D-driven pharmaceutical company specializing in the discovery, development, and commercialization of innovative and branded generic prescription drugs. The company strategically focuses on core therapeutic areas, including neuroscience, anti-oncology, and inflammatory diseases. Simcere emphasizes synergistic innovation, evidenced by its development and launch of multiple Category I innovative pharmaceuticals and its strategic collaborations with global partners to advance novel treatments. These partnerships aim to address significant unmet medical needs and expand the company's portfolio across specialized disease areas.

Recent filings

Filing Released Lang Actions
(UPDATED) FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2021
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Cash Dividend Announcement for Equity Issuer' and provides detailed information about a final dividend for the year ended December 31, 2021, including dividend amount, record date, payment date, and other related details. It is an announcement specifically about dividend amounts and payment logistics, not a full financial report or earnings release. The document length is 3461 characters, which is relatively short and consistent with a dividend announcement rather than a full report. Therefore, the document fits the category of 'Notice of Dividend Amount' (DIV).
2022-06-01 English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS: NOTICE OF PUBLICATION OF CIRCULAR AND NOTICE OF ANNUAL GENERAL MEETING AND ENVIRONMENT, SOCIAL AND GOVERNANCE REPORT
Report Publication Announcement Classification · 100% confidence The document is a notification letter addressed to non-registered shareholders regarding the publication of the company's circular, notice of annual general meeting (AGM), and the Environment, Social and Governance (ESG) report. It provides instructions on how shareholders can access these documents electronically or request printed copies. The letter explicitly states that the corporate communications include directors' reports, annual financial statements with auditors' reports, interim reports, notices of meetings, listing documents, circulars, and proxy forms. The document itself does not contain any financial statements or substantive financial data but serves as a notice of publication and availability of these reports. It is relatively short (8157 characters) and primarily functions as an announcement to shareholders about the availability of various corporate communications and ESG report. Therefore, according to the "Menu vs Meal" rule, this document is a Report Publication Announcement (RPA) rather than the actual reports (such as Annual Report or ESG report).
2022-06-01 English
PROXY FORM FOR ANNUAL GENERAL MEETING
AGM Information Classification · 95% confidence The document is a proxy form for the Annual General Meeting (AGM) of Simcere Pharmaceutical Group Limited. It includes instructions for shareholders to appoint proxies to vote on resolutions at the AGM, including adoption of financial statements, dividend declaration, director re-election, auditor appointment, and share issuance mandates. The content is procedural and related to voting at the AGM rather than the actual AGM materials or presentations. Therefore, it fits the category of AGM Information, specifically proxy forms and materials related to the AGM meeting process.
2022-06-01 English
(I) PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE AND TO REPURCHASE SHARES&#x3b; (II) PROPOSED RE-ELECTION OF RETIRING DIRECTORS&#x3b; (III) PROPOSED DECLARATION AND PAYMENT OF FINAL DIVIDEND AND (IV
AGM Information Classification · 95% confidence The document is a circular from Simcere Pharmaceutical Group Limited dated June 2, 2022, containing detailed information about the upcoming Annual General Meeting (AGM) scheduled for June 24, 2022. It includes proposed resolutions such as granting general mandates to issue and repurchase shares, re-election of retiring directors, declaration and payment of final dividend, and the notice of the AGM itself. The document also contains a proxy form and detailed explanatory statements related to the AGM agenda. The content is typical of materials sent to shareholders ahead of an AGM to inform them and solicit their votes. It is not a report of financial results, audit, or earnings, nor is it a transcript or legal proceeding update. It is not merely an announcement of a report but a full circular with substantive content related to the AGM. Therefore, the document fits the category of AGM Information (AGM-R). The document length (15,000 characters) and detailed content support this classification with high confidence.
2022-06-01 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 95% confidence The document is a notice of the Annual General Meeting (AGM) for Simcere Pharmaceutical Group Limited. It includes details about the meeting date, location, agenda items such as adoption of audited financial statements, dividend declaration, re-election of directors, appointment of auditors, and approval of share issuance and repurchase mandates. The document is a formal notice inviting shareholders to attend and vote at the AGM, not the actual AGM materials or presentations themselves. It does not contain the full financial report or detailed financial data but rather the agenda and procedural information for the meeting. Therefore, it fits the category of AGM Information (AGM-R). The document length (15,000 characters) is consistent with a detailed AGM notice rather than a brief announcement or proxy statement. Confidence is high due to the explicit title and content focused on the AGM notice.
2022-06-01 English
Environmental, Social and Governance Report 2021
Environmental & Social Information Classification · 100% confidence The document is titled as an Environmental, Social and Governance (ESG) report for the year 2021. It covers the company's ESG practices, achievements, governance, and sustainability progress. The content includes detailed sections on environmental management, social welfare, governance, and related awards and recognitions. The report is comprehensive and covers a full fiscal year (January 1 to December 31, 2021). It is not a brief announcement or a certification but a full report on ESG matters. Therefore, it fits the category of Environmental & Social Information (SR).
2022-05-31 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.